Biogen IDEC

Biogen IDEC: Products & infrastructure

Biogen IDEC holds 2 FDA approvals of new drugs and biologics. Biogen IDEC has 1 clinical trials on record, 0 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Biogen IDEC holds 2 FDA approvals of new drugs and biologics. Biogen IDEC has 1 clinical trials on record, 0 under way.

2approved drugs
1clinical trials
1EU medicine authorisations
FDA approvalsnew drugs, biologics and high-risk devices, per Drugs@FDA and PMA
Zinbryta
EU authorisation (EMA) · EMEA/H/C/003862 · daclizumab · Multiple Sclerosis
Jul 2016
Plegridy
Biologic (BLA) · BLA125499 · peginterferon beta-1a · injection
Aug 2014
Tysabri
Biologic (BLA) · BLA125104 · natalizumab · single-use
Nov 2004
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
completed · 38 participants · as a collaborator · Exercise
Jun 2010
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.